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Abstract
Background: Our aim was to analyze the relationship between abdominal obesity and general obesity, with
subclinical atherosclerosis, arterial stiffness and wave reflection in healthy, diabetics and hypertensive subjects.
Methods: A cross-sectional descriptive study was made of 305 individuals (diabetics 32.8%, hypertensive subjects
37.0% and healthy individuals 30.2%). Measurements: Body mass index (BMI), waist circumference (WC), body fat
percentage (BFP) and waist/height ratio (WHtR). Arterial stiffness was assessed according to pulse wave velocity
(PWV), intima-media thickness of the common carotid artery (C-IMT), augmentation index (central and peripheral),
ankle-brachial index (ABI), and central and peripheral pulse pressure.
Results: WC and WHtR showed a positive correlation to PWV and C-IMT in the studied groups. After adjusting for
age, gender, high sensitivity c-reactive protein, serum glucose and the presence of diabetes, hypertension,
smoking, dyslipidemia, antidiabetic drugs, lipid-lowering drugs, and atherosclerotic plaques, it was seen that for
every 0.1 point increase in WHtR, and for every cm increase in WC, the PWV increased 0.041 and 0.029 m/sec, and
C-IMT increased 0.001 mm and 0.001 mm, respectively.
Conclusions: The measures of abdominal obesity (WHtR and WC) correlates better than BMI and BFP with arterial
stiffness evaluated by PWV, and with subclinical atherosclerosis evaluated by C-IMT, independently of the presence
of diabetes or hypertension.
Trial Registration: Clinical Trials.gov Identifier: NCT01325064
Background
Obesity is a determinant factor in the development of
cardiovascular diseases, and is associated to an increased
incidence of hypertension, diabetes, metabolic syndrome
and cardiac target organ damage [1-4].
Some studies have shown measures of abdominal obe-
sity such as waist circumference (WC), waist to hip ratio
and waist/height ratio (WHtR) to be the parameters best
correlated with cardiovascular disease and mortality
[5-13]. In contrast, other studies have not found sufficient
evidence that these measures of abdominal obesity are
superior to body mass index (BMI) in predicting cardio-
vascular and cardiometabolic risk [14-21].
The vascular structure and function can be assessed
through the indices of subclinical atherosclerosis, arterial
stiffness and wave reflection [22]. A relationship has been
found between measures that assess excess body weight
or obesity to certain parameters that measure arterial
stiffness and subclinical atherosclerosis, such as the pulse
wave velocity (PWV) and the intima-media thickness of
the common carotid artery (C-IMT), though their corre-
lation to the augmentation index is not clear [23-25].
However, to our knowledge, no studies have examined
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whether this relationship differs in healthy subjects, dia-
betics and hypertensive individuals.
The present study explores the relationship between
anthropometric indices that assess abdominal obesity
(WC, WHtR) and general obesity (BMI and body fat per-
centage (BFP)), with parameters that measure arterial stiff-
ness (PWV, central and peripheral pulse pressure),
subclinical atherosclerosis (C-IMT and and ankle-brachial
index (ABI)) and wave reflection (central augmentation
index) in healthy, diabetics and hypertensive subjects.
Methods
A cross-sectional study was performed in a primary care
setting. We consecutively included all the hypertensive,
diabetics and healthy patients, that visited their family
doctor, aged 20-75 years, from January 2010 to January
2011. After dealing with the reason for consultation, the
patients were referred to the research unit for the assess-
ment of cardiovascular risk. Exclusion criteria were:
patients with intermittent claudication, and previous car-
diovascular events, patients unable to comply with the
protocol requirements (psychological and/or cognitive
disorders, failure to cooperate, educational limitations
and problems for understanding written language, failure
to sign the informed consent document), patients partici-
pating or who will participate in a clinical trial during the
study. The sample size to detect a minimum correlation
coefficient between anthropometric parameters and
arterial stiffness parameters of 0.3 in diabetic, hyperten-
sive and healthy subject with two-sided type I error rate
of 5% and 80% power was estimated to be 85 individuals
each group (total 255). We considered enough with the
305 subjects included in the study. The study was
approved by an independent ethics committee of Sala-
manca University Hospital (Spain) and all participants
gave written informed consent according to the general
recommendations of the Declaration of Helsinki [26].
Variables and measurement instruments
Anthropometric measurements
Body weight was determined on two occasions using a
homologated electronic scale (Seca 770) following due
calibration (precision ± 0.1 kg), with the patient wearing
light clothing and no shoes. These readings was rounded
to 100 g. Height in turn was measured with a portable
system (Seca 222), recording the average of two readings,
and with the patient shoeless in the standing position.
The values was rounded to the closest centimeter. Body
mass index (BMI) was calculated as weight (kg) divided
by height squared (m2). A value higher of 30 Kg/m2 was
considered obesity. Waist circumference was measured
as following: the upper border of the iliac crests are
located, and the tape is wrapped around above this point,
parallel to the floor, ensuring that it is adjusted without
compressing the skin. The reading is taken at the end of
a normal breath according to the recommendations of
the 2007 SEEDO Conference [27,28], whereas normal
when the value is below 102 cm in men and 88 cm in
women. WHtR was calculated as height (cm) divided by
waist circumference (cm), whereas normal when the
value is below 0.5 [29]. Body fat percentage was mea-
sured using a body fat monitor (OMRON, model BF306).
Blood pressure
Office or clinical blood pressure was measured involving
three measurements of systolic and diastolic blood pres-
sure, using the average of the last two measurements, with
a validated OMRON model M7 sphygmomanometer
(Omron Health Care, Kyoto, Japan). Measures were taken
in the right upper arm of participants in a sedentary posi-
tion while they were seated after having rested for at least
5 min. with an appropriately sized cuff based on the mea-
surement of arm circumference and following the recom-
mendations of the European Society of Hypertension [30].
Central blood pressure and central and peripheral
augmentation index (CAIx, PAIx) were estimated using
the SphygmoCor System. With the patient sitting and the
arm resting on a rigid surface, pulse wave in radial artery
was tested and used to estimate the aortic pulse wave
using a mathematic transformation. Inter-observer reliabil-
ity was assessed before the start of the study using an
intraclass correlation of 0.974 (95% CI: 0.936 to 0.989) in
repeated measures in 22 subjects and with Bland-Altman
analysis, where inter-observer agreement limits were 0.454
(95% CI: -9.876 to 10.785).
Pulse wave velocity (PWV) was estimated with the
SphygmoCor System (AtCor Medical Pty Ltd Head Office,
West Ryde, Australia), with the patient in the supine posi-
tion. The pulse wave of the carotid and femoral arteries
were analyzed, estimating the delay with respect to the
ECG wave and calculating PWV. Distance measurements
were taken with a measuring tape from the sternal notch
to the carotid and femoral arteries at the sensor location.
PWV higher than 12 m/sec was considered abnormal [31].
Assessment of carotid intima-media thickness (C-IMT)
Carotid ultrasonography to assess IMT was performed by
two investigators trained for this purpose before starting
the study. Reliability was evaluated before the study
began, using the intraclass correlation coefficient, which
showed values of 0.974 (95%CI: 0.935 to 0.990) for
intraobserver agreement on repeated measurements in 20
subjects, and 0.897 (95%CI: 0.740 to 0.959) for inter-
observer agreement. In turn, according to the Bland-
Altman analysis, the limit of inter-observer agreement
was 0.022 (95%CI: -0.053 to 0.098) and the limit of intra-
observer agreement was 0.012 (95%CI: -0.034 to 0.059).
A Sonosite Micromax ultrasound device paired with a 5-
10 MHz multifrequency high-resolution linear transducer
with Sonocal software was used for performing automatic
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measurements of IMT, in order to optimize reproducibil-
ity. Measurements were made of the common carotid
artery after the examination of a longitudinal section of
10 mm at a distance of 1 cm from the bifurcation, per-
forming measurements in the proximal wall, and in the
distal wall in the lateral, anterior and posterior projec-
tions, following an axis perpendicular to the artery to dis-
criminate two lines - one for the intima-blood interface
and the other for the media-adventitia interface. A total
of 6 measurements were obtained of the right carotid
and another 6 of the left carotid, using average values
(average IMT) calculated automatically by the software.
The measurements were obtained with the subject lying
down, with the head extended and slightly turned opposite
to the carotid examined, following the recommendations
of the Manheim Carotid Intima-Media Thickness Consen-
sus [32]. The average IMT was considered abnormal if it
measured > 0.90 mm, or if there were atherosclerotic pla-
ques with a diameter of 1.5 mm or a focal increase of
0.5 mm or 50% of the adjacent IMT [31].
Evaluation of peripheral artery involvement This was
evaluated using the ankle-brachial index (ABI), performed
in the morning without having consumed coffee or
tobacco for at least 8 hours prior to measuring and an
ambient temperature of 22-24°C. With the feet uncovered,
in a supine decubitus position after 20 minutes of rest, the
pressure in the lower extremities and blood pressure in
both arms was measured using a portable WatchBP Office
ABI (Microlife AG Swiss Corporation). The ABI was cal-
culated automatically for each foot by dividing the higher
of the two systolic pressures in the ankle by the highest
measurement of the two systolic pressures in the arm. ABI
lower than 0.9 was considered abnormal [31,33].
Blood samples were collected in the morning, after
patient fasting 8 h. Basal glucose, HDL cholesterol, LDL
cholesterol, total cholesterol, triglycerides and fibrinogen
were determined. High sensitivity C-reactive protein was
determined by the nephelometric method (Beckman
Instrument APS; Beckman Coulter Inc., Fullerton, CA,
USA) [34]. The parameters were measured on a blind
basis in the Hospital Biochemistry laboratory using stan-
dard automatized techniques. The HOMA index was cal-
culated as fasting insulin concentration (μU/mL) × fasting
glucose concentration (mmol/L)/22.5.
The individuals performing the different tests were
blinded to the clinical data of the patient.
Statistical analysis
The continuous variables were expressed as mean ± stan-
dard deviation, while frequency distribution was used in
the qualitative variables. The difference in means in
quantitative variables between the three groups has been
analyzed using the ANOVA for independent samples.
Non-normally distributed variables were evaluated by the
Kruskal-Wallis test, and they were log transformed for
further analysis. Because of their skewed distribution,
glucose, triglyceride, high sensitivity c-reactive protein
and HOMA were presented as median and interquartile
range. Pearson’s or Spearman correlation coefficient were
used to estimate the relationship between the quantita-
tive variables, while the chi-square test was used to
associate the qualitative variables. We performed multi-
ple linear regression analysis using PWV, C-IMT, CAIx
as dependent variables and the anthropometrics indices
as predictors following three models. First model without
adjustment. In a second model to include as adjustment
variables age and gender (male = 1; female = 0), in the
third model the presence of other cardiovascular risk fac-
tors (diabetes, hypertension, lipid lowering drugs, and
smoking) and finally in the fourth model: systolic blood
presure, total cholesterol, high sensitivity C-reactive pro-
tein, serum glucose, antidiabetic drugs and atherosclero-
tic plaques. The data were analyzed using the SPSS
version 18.0 statistical package (SPSS Inc., Chicago,
Illinois, USA). A value of P < 0.05 was considered statisti-
cally significant.
Results
Table 1 shows the clinical and demographic characteristics
of the 305 subjects included in the study (diabetics 32.8%,
hypertensive subjects 37.0% and healthy individuals
30.2%), together with the anthropometric measures,
inflammatory markers, central and peripheral arterial pres-
sure, measures of arterial stiffness, subclinical athero-
sclerosis and wave reflection.
The diabetics were older, with a higher percentage of
dyslipidemia and a greater proportion of abdominal obe-
sity and BMI > 30 than the hypertensive and healthy sub-
jects (p < 0.01), while WHtR > 0.5 was similar to that
recorded in the other groups (p = 0.066) (Figure 1).
The correlation between different anthropometric mea-
sures was high between BMI and the two abdominal obe-
sity measures (WC and WHtR) (r = 0.858 and 0.877),
moderate between BFP and BMI and WHtR, respectively
(r = 0.506 and 0.538), and discrete between BFP and WC
(r = 0.286).
The parameters assessing abdominal obesity (WC and
WHtR) showed a positive correlation to PWV and C-IMT
in the studied groups. BFP was positively correlated to the
central augmentation index (CAIx) in healthy individuals,
and to the central and peripheral augmentation indices in
healthy and hypertensive subjects. No relationship between
the arterial pressure values and anthropometric parameters
was recorded in the hypertensive individuals. Lastly, a posi-
tive correlation was observed between inflammatory mar-
kers such as high sensitivity C-reactive protein (hs-CRP)
and fibrinogen, and most of the anthropometric measures
in diabetics or hypertensive individuals (Table 2).
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Figure 2 shows the simple regression straight line of
PWV versus the anthropometric parameters.
After adjusting for age, gender and cardiovascular
risk factors, the multiple regression analysis found that
for every 0.1 point increase in WHtR, the PWV
increased 0.041 m/sec and C-IMT increased 0.001
mm. Likewise, a 1 cm increase in WC implied an
increase of 0.029 m/sec in PWV, 0.001 mm in C-IMT,
and a decrease of 0.141 in CAIx. A 1 kg/m2 increase
in BMI in turn implied an increase of 0.052 m/sec in
PWV, and a decrease of 0.270 in CAIx. Lastly, every
1% increase in BFP implied and a decrease of 0.284 in
CAIx (Table 3).
Discussion
The present study shows that the measures of abdom-
inal obesity (WHtR and WC) are better than the general
obesity indicators (BMI and BFP) in predicting arterial
stiffness as evaluated by PWV and subclinical athero-
sclerosis evaluated by C-IMT, independently of the pre-
sence of diabetes or hypertension. Therefore, WC and
WHtR are the most useful parameters for estimating
arterial stiffness in clinical practice.
A number of studies have analyzed the association
between C-IMT and abdominal and general obesity para-
meters. Yan et al. [35] reported a good correlation
between BMI and WC, though the waist-to-hip ratio was
Table 1 General demographic and clinics characteristics
Global n = 305 Healthy n = 92 (30.20) Diabetic n = 100 (32.80) Hypertensive n = 113 (37.00) p
Age 53.37 ± 12.04 48.56 ± 11.85 59.29 ± 10.56 52.05 ± 11.33 < 0.001
Male (n. %) 163 (53.40) 34 (37.00) 65 (65.00) 64 (56.60) < 0.001
Female (n.%) 142 (46.60) 58 (63.00) 35 (35.00) 49 (43.40) < 0.001
Dyslipidemia (n. %) 121 (39.70) 12 (13.00) 73 (73.00) 36 (31.90) < 0.001
Smoking (n. %) 71 (23.30) 24 (26.10) 20 (20.00) 27 (23.90) 0.597
BMI (Kg/m2) 27.92 ± 4.53 25.73 ± 3.49 29.90 ± 5.24 27.96 ± 3.75 < 0.001
Waist circumference (cm.) 95.80 ± 12.31 89.57 ± 9.53 102.32 ± 12.63 95.16 ± 11.25 < 0.001
Body fat percentage 34.06 ± 6.97 33.89 ± 7.04 34.67 ± 7.49 33.69 ± 6.47 0.589
Waist to height ratio 0.58 ± 0.08 0.54 ± 0.05 0.62 ± 0.09 0.57 ± 0.06 < 0.001
Total cholesterol (mg/dL) 205.36 ± 40.40 207.68 ± 38.70 189.81 ± 38.33 217.23 ± 39.41 < 0.001
HDL-cholesterol (mg/dL) 53.85 ± 13.70 58.10 ± 14.29 48.92 ± 11.13 54.82 ± 14.05 < 0.001
LDL-cholesterol (mg/dL) 126.28 ± 34.83 129.97 ± 34.31 111.19 ± 29.82 136.94 ± 35.01 < 0.001
Triglyceride (mg/dL) 104 (74-144.5) 80 (60.25-114.00) 118 (86.25-174.25) 109 (83.00-153.50) < 0.001
Serum glucose (mg/dL) 89 (80-107.5) 82 (77.00-88.00) 130 (106.00-149.75) 85 (78.50-93.00) < 0.001
hsCRP (mg/dL) 0.16 (0.09-0.33) 0.13 (0.06-0.23) 0.17 (0.09-0.47) 0.17 (0.09-0.29) 0.043
HOMA index 1.67 (0.98-3.02) 1.07 (0.70-1.75) 2.43 (1.49-4.24) 1.55 (1.06-2.75) < 0.001
Fibrinogen (mg/dL) 320.52 ± 62.51 319.88 ± 60.11 328.77 ± 67.29 313.73 ± 59.62 0.224
Office SBP (mmHg) 133.61 ± 19.50 115.23 ± 14.21 137.10 ± 18.68 145.48 ± 11.37 < 0.001
Office DBP (mmHg) 84.21 ± 12.27 74.40 ± 8.92 83.10 ± 11.33 93.18 ± 8.33 < 0.001
Peripheral pulse pressure (mmHg) 49.40 ± 12.77 40.83 ± 8.93 54.00 ± 13.39 52.31 ± 11.46 < 0.001
Central SBP (mmHg) 125.28 ± 19.57 107.52 ± 13.69 128.86 ± 17.82 137.86 ± 12.95 < 0.001
Central DBP (mmHg) 84.87 ± 12.86 74.71 ± 9.41 84.31 ± 11.67 94.36 ± 8.87 < 0.001
Central Pulse pressure (mmHg) 40.41 ± 12.12 32.82 ± 8.48 44.55 ± 12.17 43.50 ± 11.78 < 0.001
PWV (m/s) 8.59 ± 2.29 7.03 ± 1.42 9.84 ± 2.35 8.80 ± 2.08 < 0.001
C-IMT mean (mm.) 0.71 ± 0.11 0.64 ± 0.09 0.77 ± 0.12 0.70 ± 0.10 < 0.001
C-IMT maximum (mm.) 0.88 ± 0.14 0.80 ± 0.11 0.96 ± 0.14 0.87 ± 0.12 < 0.001
CAIx 30.33 ± 12.07 29.27 ± 13.28 30.77 ± 11.33 30.89 ± 11.61 0.592
PAIx 91.51 ± 20.67 88.27 ± 19.74 94.73 ± 22.96 91.63 ± 19.11 0.109
ABI 1.11 ± 0.13 1.15 ± 0.11 1.09 ± 0.15 1.11 ± 0.11 0.002
Antihypertensive drugs (n. %) 72 (23.6) 0(0.0) 70 (70.0) 2 (1.8) < 0.001
Antidiabetic drugs (n. %) 87 (28.5) 0(0.0) 87 (87.0) 0(0.0) < 0.001
Lipid lowering drugs (n. %) 69 (22.6) 0(0.0) 58 (58.0) 11 (9.7) < 0.001
Atherosclerotic plaques (n. %) 37 (12.1) 1 (1.1) 25 (25.0) 11 (9.7) < 0.001
BMI: Body mass index. HDL: High-density lipoprotein. LDL: Low-density lipoprotein. hsCRP: High sensitivity c-reactive protein. SBP: Systolic blood pressure. DBP:
Diastolic blood pressure. PWV: Pulse wave velocity. C-IMT:Intima-media thickness. CAIx: Central augmentation index. PAIx: Peripheral augmentation index. ABI:
ankle-brachial index.
Data for qualitative variables are expressed as n (%) and quantitative variables as mean ± standard deviation or mean (interquartile range)
p: statistically significant differences (p < 0.05).
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the parameter that best predicted C-IMT. In the study of
Maher et al. [36], after adjusting for age, gender and the
presence of cardiovascular risk factors, WHtR and BMI
were seen to maintain their relationship to C-IMT. In
both studies, and coinciding with the results of earlier
publications [37], the measures that adjust WC were seen
to be the best predictors of C-IMT. We did not measure
the waist-to-hip-ratio, though another parameter that
adjusts WC according to height was used, i.e., WHtR.
However, in contrast to other studies, our findings were
confirmed in all three patient groups considered (healthy
individuals, diabetics and hypertensive subjects).
Likewise, we found a positive correlation between the
anthropometric measures and PWV. Our results are in
line with the observations of Ko et al. [23] and Wildman
et al. [25]. Again, the behavior proved similar in all three
groups studied.
Since the arterial stiffness is a surrogate marker
between the appearance of risk factors and cardiovascu-
lar outcomes, our findings support the importance of
anthropometric measures as a risk factors [38].
Maher et al. examined the relationship between the
augmentation index and the anthropometric indices -
only age being found to remain on performing the mul-
tivariate analysis. We did record a significant relation-
ship, though of a negative sign. This may have been due
to the fact that in our series the obese individuals (BMI
> 30 kg/m2) presented a CAIx of 31.3 versus 28.0 in
those with BMI < 30. In the case of BFP, the behavior
was not uniform among the three groups. BFP was posi-
tively correlated to the CAIx in healthy individuals, and
to the central and peripheral augmentation indices in
healthy and hypertensive subjects - no such relationship
being observed among diabetics.
In contrast to Tison et al. [39], we observed no rela-
tionship between the different anthropometric indices
and ABI, and no consistent relationship with the arterial
pressure measures (central and peripheral). This fact
was more relevant in the hypertensive group - antihy-
pertensive treatment being the most likely explanation.
Figure 1 Percentage of subjects in each group with body mass
index greater than 30 Kg/m2, waist circumference greater than
102 cm in men and 88 cm in women and waist/height ratio
greater than 0.5.
Table 2 Pearson correlations between arterial stiffness and anthropometrics measurements
Healthy n = 92 (30.20) Diabetic n = 100 (32.80) Hypertensive n = 113 (37.00)
BMI WC BFP WHtR BMI WC BFP WHtR BMI WC BFP WHtR
Office SBP (mmHg) 0.114 0.285** -0.257* 0.126 0.299** 0.379** 0.034 0.343** 0.009 0.016 -0.051 0.058
Office DBP (mmHg) 0.141 0.195 -0.151 0.112 0.457** 0.433** 0.142 0.409** 0.037 0.045 0.022 0.009
Peripheral pulse pressure (mmHg) 0.041 0.259* -0.258* 0.089 0.031 0.163 -0.073 0.133 -0.018 -0.017 -0.070 0.052
Central SBP (mmHg) 0.068 0.187 -0.140 0.122 0.267* 0.322** 0.033 0.315** -0.146 -0.156 -0.037 -0.041
Central DBP (mmHg) 0.211* 0.249* -0.125 0.156 0.367** 0.350** 0.050 0.316** 0.022 0.032 0.044 0.021
Central Pulse pressure (mmHg) -0.124 0.026 -0.087 0.024 0.038 0.136 0.001 0.158 -0.177 -0.195* -0.079 -0.061
PWV (m/s) 0.078 0.209* 0.013 0.219* 0.230* 0.342** 0.163 0.357** 0.232* 0.267** 0.203* 0.335**
C-IMT mean (mm.) 0.093 0.228* 0.008 0.271** 0.053 0.229* -0.074 0.176 0.223* 0.249** 0.101 0.306**
C-IMT maximum (mm.) 0.039 0.174 0.001 0.215* 0.051 0.231* -0.072 0.177 0.257** 0.280** 0.108 0.325**
CAIx -0.207* -0.193 0.306** 0.054 -0.105 -0.150 0.063 -0.007 -0.284** -0.285** 0.106 -0.083
PAIx -0.215* -0.172 0.300** 0.069 -0.057 -0.120 0.167 0.027 -0.115 -0.229* 0.263** 0.031
ABI 0.063 0.090 0.205 0.132 -0.114 -0.149 -0.075 -0.125 0.031 -0.060 -0.073 0.010
Fibrinogen (mg/dL) 0.172 -0.015 0.299** 0.211 0.337** 0.401** 0.287** 0.435** 0.202* 0.184 0.233* 0.257**
hsCRP (mg/dL) 0.306** 0.288** 0.180 0.301** 0.442** 0.442** 0.356** 0.475** 0.214* 0.266** 0.251* 0.316**
HOMA index 0.246 0.126 0.087 0.093 0.231* 0.303** 0.179 0.247* 0.427** 0.444** 0.108 0.465**
BMI: Body mass index. WC: Waist circumference. BFP: Body fat percentage. WHtR: Waist to height ratio SBP: Systolic blood pressure. DBP: Diastolic blood pressure.
PWV: Pulse wave velocity. C-IMT: Carotid intima-media thickness. CAIx: Central augmentation index. PAIx: Peripheral augmentation index. ABI: ankle-brachial
index. hsCRP: High sensitivity c-reactive protein. p: statistically significant differences * p < 0.05 ** p < 0.01
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Figure 2 PWV values plotted against anthropometric indices (WC, WHtR and BMI). The figures show regression line.
Table 3 Models with PWV, C-IMT, and CAIx as dependent variables and anthropometric indices as predictors.
PWV C-IMT CAIx
R2: b 95% CI p R2: b 95% CI p R2: b 95% CI p
1st
model
0.115 0.173 0.118 to 0.228 <
0.001
0.068 0.007 0.004 to 0.009 <
0.001





0.399 0.127 0.081 to 0.173 <
0.001





0.453 0.091 0.044 to 0.138 <
0.001
0.504 0.002 < 0.001 to
0.005










0.178 0.080 0.060 to 0.099 <
0.001
0.144 0.004 0.003 to 0.004 <
0.001







0.413 0.056 0.038 to 0.075 <
0.001
0.486 0.002 0.001 to 0.003 <
0.001





0.470 0.045 0.026 to 0.063 <
0.001
0.511 0.001 < 0.001 to
0.002














0.642 0.028 0.295 0.086 to 0.504 0.006
% Fat 2nd
model
0.368 0.070 0.033 to 0.107 <
0.001
0.441 0.001 -0.001 to
0.003





0.443 0.055 0.019 to 0.090 0.003 0.483 0.001 -0.001 to
0.002





0.527 0.033 -0.003 to
0.069
0.075 0.548 0.590 -0.001 to
0.002









0.149 0.584 0.425 to 0.742 <
0.001









0.479 0.251 0.117 to 0.384 <
0.001





0.466 6.915 3.941 to 9.889 <
0.001





0.530 4.062 0.911 to 7.212 0.012 0.557 0.143 -0.003 to
0.290
0.050 0.259 -19.957 -41.377 to
-1.463
0.068
PWV: Pulse wave velocity. C-IMT: Intima media thickness.CAIx: Central augmentation index. BMI: Body mass index. % Fat: body fat percentage. WHtR: Waist to
height ratio.
p: statistically significant differences (p < 0.05).
First model: No adjusted.
Second model: Regression model constructed with BMI, waist circumference, body fat percentage and waist height ratio as predictors variables adjusted by
gender and age.
Third model: Regression model constructed with BMI, waist circumference, body fat percentage and waist height ratio as predictors variables adjusted by gender,
age, to be diabetic, to be hypertensive, lipid lowering drugs and smoking.
Fourth model: Regression model constructed with BMI, waist circumference, body fat percentage and waist height ratio as predictors variables adjusted by
gender, age, to be diabetic, to be hypertensive, lipid lowering drugs, smoking, systolic blood pressure, total cholesterol, high sensitivity c-reactive protein, serum
glucose, antidiabetic drugs and atherosclerotic plaques.
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The main limitation of our study is its cross-sectional
design, which precludes the definition of causality and
analysis of the behavior over time of the different stiff-
ness parameters in relation to the different anthropo-
metric indices considered. On the other hand, with a
study design of this kind it would also be necessary to
increase the sample size, since a larger number of indivi-
duals in each group (healthy, diabetic and hypertensive)
could help clarify which anthropometric parameters are
best related to arterial stiffness in each of them.
Conclusions
Based on the results obtained in our study, it can be
concluded that, independently of the presence of dia-
betes or hypertension, the measures of abdominal obe-
sity (WHtR and WC) correlates better than BMI and
BFP with arterial stiffness and subclinical atherosclerosis
evaluated by PWV and C-IMT respectively. However,
the association with wave reflection (evaluated by CAIx)
was better with general adiposity measures.
List of abbreviations
BMI: Body mass index; WC: Waist circumference; BFP: Body fat percentage;
WHtR: Waist/height ratio; C-IMT: Intima-media thickness of the common
carotid artery; PWV: Pulse wave velocity; CAIx: Central augmentation index;
ABI: Ankle brachial index.
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